Delivery Order SPE2DB24D2100-SPE2DB25FBFRT
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,644.08 by the Defense Department's Medical Supply Chain to deliver XOLAIR 150 mg/mL syringes. The contract, awarded on July 15, 2025, is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and carries no set-aside designation. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,644.08 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes, with an ultimate completion date of August 27, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,881.40 by the Defense Logistics Agency for XOLAIR 150 mg/ml syringes. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by May 15, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $2,881.36 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/ml syringe. The contract is a firm fixed price delivery order with an ultimate completion date of June 17, 2025, and represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $72,034 delivery order to AmerisourceBergen Drug Corp on July 3, 2025, for the supply of Xolair 150 mg/mL syringes, with completion scheduled for July 25, 2025. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Defense Department's Medical Supply Chain has awarded a delivery order valued at $72,034.00 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/ml syringes, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical vendor supporting federal military and veteran healthcare systems. The award carries no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,203.44 for Xolair 150 mg/mL syringes, with an ultimate completion date of June 24, 2025. This competitive award, issued on June 2, 2025, carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428....
- The Defense Logistics Agency awarded a $10,805.10 delivery order to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be performed at the vendor's Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract awarded on July 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Xolair 150 mg/1.2 ml powder vials. The award, issued on July 21, 2025, carries a ceiling value of $16,685.00 and is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025. This non-set-aside award was competitively awarded and represents a discrete delivery under a...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFRTDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $61,999.85 by the Defense Logistics Agency (DLA) for the supply of Xolair 150 mg/mL syringes, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies an extensive range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Xolair delivery supports the DLA Medical Supply Chain's mission to provide specialty pharmaceutical products, including immunology and allergy treatment medications, to military and veteran healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.0k | 8/6/25 |